Vimarsana
Biggest News Aggregation in the World

David Katona News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Katona. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Katona Today - Breaking & Trending Today

Collection of books thought to be lost headed for new life at Nigerian orphanage - Vimarsana News

Collection of books thought to be lost headed for new life at Nigerian orphanage

More than 9,000 books were discovered in a room. Here's how they will find new life on another continent.

St. Alphonsus school and convent demolished - Vimarsana News

St. Alphonsus school and convent demolished

The buildings housing the former St. Alphonsus schools and convent are being torn down, with demolition beginning Tuesday.

Source: freep.com
VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System - Vimarsana News

VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System

/PRNewswire/ -- VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today...

ITM Raises EUR 90 M (USD 109 M) to Accelerate Precision Oncology Pipeline and Support Ongoing Phase 3 Clinical Program - Vimarsana News

ITM Raises EUR 90 M (USD 109 M) to Accelerate Precision Oncology Pipeline and Support Ongoing Phase 3 Clinical Program

(0) Financing led by Petrichor Healthcare Capital Management strengthens company's global position as a leader in precision oncology and the field of Targeted Radionuclide Therapy ITM AG announced today the successful close of a convertible loan financing totaling EUR 90 million (USD 109 million) led by Petrichor Healthcare Capital Management with participation of additional undisclosed investors. The proceeds will support the expansion of ITM's precision oncology pipeline as well as fund late-stage development and market access activities for lead candidate, n.c.a. 177Lu-Edotreotide, c...